We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

149 hedge funds and large institutions have $1.25B invested in Intra-Cellular Therapies Inc. in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $91M | Put options by funds: $41.1M

88% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 32

66% more capital invested

Capital invested by funds: $755M → $1.25B (+$497M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

7% more funds holding

Funds holding: 139 → 149 (+10)

Holders
149
Holders Change
+10
Holders Change %
+7.19%
% of All Funds
3.06%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
33
Increased
60
Reduced
32
Closed
22
Calls
$91M
Puts
$41.1M
Net Calls
+$49.8M
Net Calls Change
+$46.6M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.9M
2
WA
Wasatch Advisors
Utah
+$14.7M
3
Marshall Wace
Marshall Wace
United Kingdom
+$12.8M
4
BlackRock
BlackRock
New York
+$11.5M
5
PA
Pinnacle Associates
New York
+$5.58M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$25.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.8M
3
CS
Candriam SCA
Luxembourg
-$6.54M
4
Millennium Management
Millennium Management
New York
-$5.43M
5
IC
Ikarian Capital
Texas
-$4.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASRS
101
Arizona State Retirement System
Arizona
$348K -$4.86K -240 -2%
MPCG
102
Matrix Private Capital Group
New York
$347K +$30.4K +1,500 +13%
GAM
103
Gemmer Asset Management
California
$347K +$50.6K +2,500 +23%
LPL Financial
104
LPL Financial
California
$336K +$20.5K +1,015 +8%
Jacobs Levy Equity Management
105
Jacobs Levy Equity Management
New Jersey
$315K – – –
Wolverine Trading
106
Wolverine Trading
Illinois
$311K +$250K +12,346 New
HSBC Holdings
107
HSBC Holdings
United Kingdom
$306K +$242K +11,940 New
Handelsbanken Fonder
108
Handelsbanken Fonder
Sweden
$293K +$231K +11,400 New
SEI Investments
109
SEI Investments
Pennsylvania
$291K -$1.27K -63 -0.6%
PM
110
Parametrica Management
Hong Kong
$290K +$229K +11,296 New
VHAM
111
Van Hulzen Asset Management
California
$272K +$215K +10,600 New
Public Employees Retirement Association of Colorado
112
Public Employees Retirement Association of Colorado
Colorado
$266K – – –
Nisa Investment Advisors
113
Nisa Investment Advisors
Missouri
$265K +$9.55K +472 +5%
Baird Financial Group
114
Baird Financial Group
Wisconsin
$257K +$202K +10,000 New
HHAM
115
HITE Hedge Asset Management
Massachusetts
$247K +$195K +9,624 New
CSS
116
Cubist Systematic Strategies
Connecticut
$226K +$178K +8,800 New
SAM
117
Sectoral Asset Management
Quebec, Canada
$216K +$170K +8,400 New
FC
118
FORA Capital
Florida
$203K +$160K +7,919 New
TRCT
119
Tower Research Capital (TRC)
New York
$192K +$151K +7,471 New
IC
120
Ikarian Capital
Texas
$185K -$4.89M -241,800 -97%
Russell Investments Group
121
Russell Investments Group
United Kingdom
$185K +$147K +7,245 New
Zurich Cantonal Bank
122
Zurich Cantonal Bank
Switzerland
$162K +$32.3K +1,597 +34%
Royal Bank of Canada
123
Royal Bank of Canada
Ontario, Canada
$125K -$47.3K -2,336 -32%
SO
124
STRS Ohio
Ohio
$125K +$99.2K +4,900 New
AIP
125
Ameritas Investment Partners
Nebraska
$118K – – –
3 4
5
6 7

ITCI Hedge Fund Activity: Q2 2020 in Review

149 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2020, worth a combined $1.25B — up 66% from $755M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ITCI positions and 22 closed out — a net gain of 11 holders — while 60 added to existing stakes and 32 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.9M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $25.4M sold.

  • 149 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2020, up from 139 in Q1 2020.
  • Funds reported $1.25B of Intra-Cellular Therapies Inc. stock for Q2 2020, up 66% quarter-over-quarter.
  • 33 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2020 and 22 closed out, a net change of +11 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q2 2020 was Fidelity Investments, an estimated $15.9M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q2 2020 was Consonance Capital Management, an estimated $25.4M sold.

Based on aggregated 13F filings for Q2 2020.